12:00 AM
Jan 25, 2010
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Cyclacel completes direct public offering

Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC), Berkeley Heights, N.J.
Business: Cancer
Date completed: 1/21/10
Type: Direct public offering...

Read the full 60 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >